Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives.
Li M, Xue N, Liu X, Wang Q, Yan H, Liu Y, Wang L, Shi X, Cao D, Zhang K, Zhang Y.
Li M, et al. Among authors: zhang k, zhang y.
Front Pharmacol. 2021 May 26;12:647591. doi: 10.3389/fphar.2021.647591. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34122069
Free PMC article.